Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Developing oncolytic virotherapy treatments for a range of cancers such as Melanoma, bladder cancer.
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Other / undisclosed | 1 | 50% |